Podcast
 |
| Eric Topol, chief medical officer of the West Wireless Health Institute, discusses consumer digital healthcare and how the convergence of technologies is empowering patients, attacking the high cost of chronic diseases, and making the long-sought promise of personalized medicine a reality. |
G. Steven Burrill
Welcome from the CEO
Flash required to view this video. Download the latest version here
G. Steven BurrillBurrill Conferences
Life Sciences Conferences
The Burrill India Life Sciences Meeting
AgendaPreliminary Agenda
June 16, 2008
7:30 a.m. – 8:00 a.m.
Breakfast & Registration
8:00 a.m. – 8:45 a.m.
Keynote Presentation:
G. Steven Burrill, CEO, Burrill & Company
8:45 a.m. – 9:00 a.m.
China / San Diego / California - Global Biotech Cluster
Joe Panetta, President & CEO, BIOCOM
9:00 a.m. -9:15 a.m
Break
9:15 a.m. – 10:30 a.m.
The Life Science Revolution in
• Areas of Innovation that
- Rashmi Barbhaiya, PhD, CEO & Managing Director, Advinus Therapeutics
- Ajit Singh, PhD, CEO, Siemens Healthcare, Image & Knowledge
Management Group
• Reaching Beyond: From Domestic to International Markets
- Arun Chandavarkar, PhD, COO, Biocon
- Greg Wiederrecht, PhD, VP External Scientific Affairs, Merck
• Creating Value in a Global Marketplace
- Sreeni Devidas, PhD VP, Business Development, GVK BioSciences
- Dr. Swati Piramal, Director, Strategic Alliances & Communications, Nicholas
Piramal India Ltd
Moderated by: Tania Fernandez, PhD, Director India, Burrill & Comapny
10:30 a.m – 11:45 a.m.
Models of Global Growth by Leading Indian Companies
• Expansion into US Specialty Therapeutics
- Jeffrey Wasserstein, EVP, North America Specialty, Dr. Reddy’s
Laboratories
• Leadership in Global Generics through Regional Expansion
- Shyam Bishen, PhD, VP, Corporate Development, Ranbaxy Pharmaceuticals
• Transitioning from Services to Proprietary Drug Development
- Venkat Jasti, Vice Chairman & CEO, Suven Life Sciences
• Vertical Integration Via M&A
- Sridhar Mosur, President & CEO, Jubilant Discovery Services &
Jubilant Biosys
• Growth Through Strategic Partnerships
- Andres Liivak, Partner, Reed Smith
Moderated by: Mohan Iyer, Managing Director, Merchant Banking Group, Burrill
& Company
11:45 a.m. – 12:45 p.m.
Networking Lunch
12:45 p.m. – 2:00 p.m.
Capital Markets in
• Where is the Capital Coming From?
- Anna Lavelle, PhD, CEO & Executive Director, AusBiotech
- Robert Power, VP, Investment Banking, NYSE Euronext
- Villoo Morawalla Pate, PhD, Founder and Managing Director of Avestha
Gengraine Technologies
• How Can You Build Value in Indian Life Science Companies?
- Dr. Anula Jayasuriya, PhD, Managing Director, Evolvence
Fund
2:00 p.m. – 2:45 p.m.
Shining examples of Indian life science companies on the horizon
- Advinus (Pharma): Kasim Mookhtiar, PhD, CSO & SVP
- Chembiotek- A TCG Lifesciences Co. (Discovery Services): Ashis Saha, PhD, VP, Discovery
- MetaHelix Life Sciences (Agbio): Dr. Vasudera Rao, President, Agriculture Technologies
- Ocimum Biosolutions (Services): Anuradha Acharya, CEO
Moderated by: Ganesh Kishore, PhD, Managing Director, Burrill & Company
2:45 p.m. – 3:00 p.m.
Break
3:00 p.m. – 3:45 p.m.
Year 2020 – China/India: A Comparison
• Futurist who can find what
Rashmi Barbhaiya, PhD, CEO & Managing Director, Advinus Therapeutics
• Futurist who can find what
Hongguang Wang,PhD, Director General,
Biotechnology
Moderated by: G. Steven Burrill, CEO, Burrill & Company
3:45 p.m. – 4:00 p.m.
Closing Remarks
G. Steven Burrill, CEO, Burrill & Company
4:00 p.m. – 5:30 p.m.
Networking Reception
Sponsored by: Wilson Sonsini Goodrich & Rosati